BioSpace News Archive

Policy

Shareholder Alert: Ademi & O’Reilly, LLP Investigates whether Progenics Pharmaceuticals, Inc. has obtained a Fair Price in its sale to Lantheus Holdings, Inc.

Ademi & O’Reilly, LLP is investigating Progenics (Nasdaq: PGNX) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Progenics to Lantheus.

October 3, 2019
·
1 min read
Business

Median Technologies Reports Its Financial Results for H1 2019

Median Technologies (Paris:ALMDT) (ALMDT), The Imaging Phenomics Company®, today announced its results for the first half of 2019.

October 3, 2019
·
6 min read
Business

Independence Blue Cross Opens State-of-the-Art Innovation Center

The newly designed space will support the company’s external and internal innovation efforts

October 3, 2019
·
4 min read
Business

Standardized Vascular Access Protocol Improves Patient Safety and Reduces Costs of Peripheral IV Catheter Insertions

Implementation of a standardized set of best practices for inserting peripheral intravenous catheters (PIVC) resulted in significant clinical and economic benefits, according to a newly published study from Hartford Hospital (Hartford, Conn.) and PICC Excellence.

October 3, 2019
·
4 min read
BioMidwest

BiomeSense Raises $2 Million in Seed Round Funding

BiomeSense, a microbiome startup developing a novel biosensor and analytics platform for daily gut microbiome tracking, announced today that it has closed its $2 million seed funding round.

October 3, 2019
·
3 min read
Genetown

Verastem Oncology Receives Orphan Drug Designation from FDA for COPIKTRA for the Treatment of T-Cell Lymphoma

Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced duvelisib (COPIKTRATM) has received orphan drug designation from the U.S. Food and Drug Administration for use in the treatment of T-Cell lymphoma.

October 3, 2019
·
9 min read
Deals

Heron Therapeutics Announces Proposed Public Offering of Common Stock - Oct. 3, 2019

Heron Therapeutics, Inc. announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering.

October 3, 2019
·
3 min read
FDA

FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic

The U.S. Food and Drug Administration approved Descovy in at-risk adults and adolescents weighing at least 35kg for HIV-1 pre-exposure prophylaxis to reduce the risk of HIV-1 infection from sex, excluding those who have receptive vaginal sex.

October 3, 2019
·
3 min read
Pharm Country

Minnesota’s Psychiatric Assistance Line receives the 2019 Community Gold Award from the American Psychiatric Association

The American Psychiatric Association recognized the state of Minnesota as a national leader in increasing access to psychiatric health care.

October 3, 2019
·
1 min read
Business

AMN Healthcare to Host Third Quarter 2019 Earnings Conference Call on Thursday, October 31, 2019

AMN Healthcare Services, Inc., healthcare’s leader and innovator in workforce solutions and staffing services, has scheduled a conference call to discuss its third quarter 2019 financial results on Thursday, October 31, 2019 at 5:00 p.m. Eastern Time.

October 3, 2019
·
3 min read